Allarity Therapeutics, Inc.

Develops personalized cancer drugs using a diagnostic platform to predict patient response.

ALLR | US

Overview

Corporate Details

ISIN(s):: US0167445008
LEI:
Country:: United States of America
Address:: 24 SCHOOL ST., 2ND FLOOR, 2108 BOSTON
Website:: https://allarity.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company focused on developing personalized cancer treatments. The company leverages its proprietary Drug Response Predictor (DRP®) technology, a diagnostic platform that analyzes tumor biology to predict a patient's response to specific therapies. This approach aims to refine patient selection and improve clinical outcomes for its pipeline of in-licensed oncology therapeutics. Allarity's lead clinical program is stenoparib, an orally available, dual-action small molecule inhibitor being advanced for patients with advanced recurrent ovarian cancer. The company's mission is to enhance patient outcomes through data-driven decision-making and personalized cancer care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Allarity Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Allarity Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Allarity Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
PEPTONIC Medical AB Develops clinically proven self-care products for women's intimate health.	Sweden	PMED
Peptron, Inc. Develops sustained-release peptide medicines for chronic & neurodegenerative disorders.	South Korea	087010
PERRIGO Co plc World's largest manufacturer of store-brand OTC consumer health products.	United States of America	PRGO
Perseus Proteomics Inc. Develops antibody drugs for cancer, provides research support, and sells diagnostic reagents.	Japan	4882
Personalis, Inc. Cancer genomics & liquid biopsy for early recurrence detection & guiding precision therapies.	United States of America	PSNL
Perspective Therapeutics, Inc. Developing targeted alpha radiotherapies using lead-212 to image and treat solid tumors.	United States of America	CATX
PharmAbcine Inc. Develops antibody therapies for cancer, eye diseases, and vascular-related disorders.	South Korea	208340
Pharma Foods International Co., Ltd. Researches and sells functional ingredients and direct-to-consumer health & beauty products.	Japan	2929
Pharma Mar S.A. Develops and commercializes marine-derived oncology treatments for rare cancers.	Spain	PHM
Pharmanutra Researches and markets nutritional supplements & medical devices for all ages.	Italy	PHN